Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Lymphoma, Mantle-Cell × Steroids × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 3 Radiation Injuries 1 Prostatic Neoplasms 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Hepatitis 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Chemical and Drug Induced Liver Injury 1 Brain Injuries 1 Bone Cysts 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Anatomic Stage I Breast Cancer AJCC v8 1

Interventions

Rituximab 107 Cyclophosphamide 95 fludarabine phosphate 45 Peripheral Blood Stem Cell Transplantation 44 Cytarabine 43 Etoposide 39 Mycophenolic Acid 37 Filgrastim 36 Whole-Body Irradiation 34 Bortezomib 32 Tacrolimus 31 Methotrexate 31 Melphalan 29 Cyclosporine 29 Radiotherapy 28 Vincristine 27 Busulfan 27 Doxorubicin 26 Dexamethasone 26 Antilymphocyte Serum 23 Carmustine 22 Bendamustine Hydrochloride 22 Lenalidomide 21 ibrutinib 20 Granulocyte Colony-Stimulating Factor 17 fludarabine 16 Prednisone 16 zanubrutinib 15 venetoclax 15 obinutuzumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00946374 2009-07-27

HD-MCL2003

Heidelberg University

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡